QualityStocksNewsBreaks Archives - Page 732 of 1386

ThursdayFeb 11, 2021 11:14 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Launches Innovative New CBD Products, Commences Trading on the OTCQX

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has announced increase of its product offering to 48 SKUs by introducing its new and improved sleep and stress products with twice the amount of CBD per serving. “Global consumers are becoming increasingly familiar with CBD and its potential benefits to their daily routine,” said Jason Mitchell, N.D., HempFusion’s co-founder and chief executive officer. “After conducting months of extensive consumer research, it was clear that the majority of our customers and consumers in the market are seeking products…

ThursdayFeb 11, 2021 11:02 am

QualityStocksNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd.’s (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Hemp-Based Substitute Mimics Traditional Tobacco Cigarette Experience

TAAT(TM) (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) today announced that, in a world where re-invented consumer packaged goods (“CPG”) of perceived unhealthy or environmentally harmful products are all the rage, the company is attempting to forge its own niche. TAAT is introducing a hemp-based substitute that mimics the experience of a traditional tobacco cigarette in an attempt to steal market share from Big Tobacco, as well as grow sales organically. The company’s cigarettes are formulated using a house blend of CBD-containing hemp called Beyond Tobacco(TM). Hemp is blended with patented ingredients and refined to replicate the experience of a conventional…

ThursdayFeb 11, 2021 10:16 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Ability to Speed Up COVID-19 Testing Using PCR Equipment

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, has partnered with a German diagnostics firm to become a leader in commercializing breakthrough tech in rapid, definitive testing for COVID-19 in strategic and convenient point-of-care (“POC”) settings. A recent article noted that, using standard polymerase chain reaction (“PCR”) equipment, XPhyto has the ability to significantly speed up testing for COVID-19. The equipment is commonly found in most analytical laboratories as well as hospitals and a range of POC settings. The announcement was based on the successful trial validation results of XPhyto’s…

ThursdayFeb 11, 2021 10:11 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces $7.4M Registered Direct Offering

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced its entry into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of approximately 4,222,288 shares of its common stock. The company expects gross proceeds of approximately $7.4 million, with each of the shares sold a purchase price of $1.75, in the registered direct offering priced at-the-market under Nasdaq rules. Predictive Oncology has also agreed to issue to the investors unregistered warrants to purchase up to an aggregate of approximately 2,111,114 shares…

ThursdayFeb 11, 2021 9:49 am

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Conference Call to Focus Fiscal Q3 2021 Business Results

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters, and CBD-infused products, has announced an upcoming conference call. The Feb. 16, 2021 call is scheduled to start at 5 p.m. ET and will discuss financial results and business updated for fiscal third-quarter 2021. The call will be hosted by WTER president and CEO Richard Wright and chief financial officer David Guarino. The company noted that the teleconference will include investors and analysts. Following the call, the company will also release its financial results and business update; the same information will be posted on…

ThursdayFeb 11, 2021 9:13 am

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Closes on Private Placement, Resulting in C$5.3 Million

PowerBand Solutions’ (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) has announced that the company has closed on its previously announced nonbrokered private placement. As announced on Jan. 22, 2021, the placement was comprised 18,275,862 units; each unit, which included one common share of the company and one share purchase warrant of the company, was sold at $0.29. In addition, each warrant holder allows the holder to receive on common share for no additional consideration for an exercise price of $0.49 per share for up to 24 months after their date of issuance. The private placement was fully subscribed, resulting in total…

WednesdayFeb 10, 2021 3:14 pm

QualityStocksNewsBreaks – United Medical Equipment Business Solutions Network Inc. Provides Antigen Rapid POC Test as part of Comprehensive COVID-19 Strategy

United Medical Equipment (“UME,” “UMEBSNI”) is committed to offering high-quality COVID-19 services, solutions and supplies. Among these, UME provides the CareStart(TM) COVID-19 Antigen Rapid POC test. The test can be administered by authorized laboratories and at the point of care by medical professionals to detect the presence of the SARS-CoV-2 nucleocapsid protein antigen. The innovative test features a 10-minute processing time and provides the capability to identify acute infection with 88.4% sensitivity and 100% specificity. A recent article discussing this reads, “The CareStart product is part of a UME’s comprehensive COVID-19 monitoring strategy, which was carefully designed with the assistance…

WednesdayFeb 10, 2021 3:03 pm

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Anticipates ‘Breakout Year’ in 2021

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, expects to achieve important milestones in the year ahead. The company’s proprietary i/Blue Imaging System is designed to significantly enhance surgeons’ ability to visualize and remove cancer cells using blue light by combining advanced optics and light sensors with a contrast imaging agent. The system’s key feature is its adaptability to almost any scope already in use by hospitals and surgical centers. Despite the challenges of 2020, Imagin was able to transition its product from the development stage to manufacturing, contracting with FDA registered and ISO 13485:2016-certified manufacturer Lighthouse Imaging.…

WednesdayFeb 10, 2021 2:53 pm

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSXV: ISGI) (OTCQB: ISGIF) Poised as Insurtech Disrupts the Insurance Industry

InsuraGuest Technologies (TSXV: ISGI) (OTCQB: ISGIF) is positioned as technology has become a key factor and is generating significant changes in the insurance industry. The combination of insurance and technology (insurtech) is disrupting the insurance industry in its entirety, delivering better processes, efficiencies and customer experiences and new cost-saving solutions. A leader in the insurtech sector, InsuraGuest continues to expand its already impressive reach into multiple insurance markets. A recent article discussing this reads, “The company’s first target is the hospitality sector with intent to dominate what looks to be an incredibly lucrative segment. InsuraGuest Technologies’ latest landmark is the…

WednesdayFeb 10, 2021 1:58 pm

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Secures $24.2M in Initial Public Offering

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company that offers novel and proprietary alternatives for treating mild-to-moderate obstructive sleep apnea, has closed its initial public offering of 4,025,000 shares of its common stock, including an additional 525,000 shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, Vivos Therapeutics secured approximately $24.2 million in gross proceeds, with each of the shares sold at the public offering price of $6.00. The common stock shares began trading on the Nasdaq Capital Market under the ticker symbol "VVOS" on Friday, Dec. 11, 2020. ROTH Capital Partners…

Site Search

Company Search

Category: QualityStocksNewsBreaks